HOMEOPHATY WAS INITIATED IN THE XVIII CENTURY, IT IS, MORE THAN 200 YEARS AGO AND IT WAS BORN IN GERMANY.

THE HOMEOPHATIC PHARMACY HAS NOWADAYS MORE THAN 3000 RECOGNIZED PRODUCTS FROM THE VEGETAL, MINERAL AND ANIMAL KINGDOMS. INTRODUCCIONTHEY ARE USED IN TREATMETS OF ACUTE AND CHRONIC DISEASES IN HUMANS.

70 % DEL COMERCIO ESTA EN EUROPA.Statystical data 2010

Countries leading the Homeophatic MarketContinents United States of America750 Million Eur.FranceEurop 405 Million Eur.IndiaAsia390 Million EurGermanyEurop270 Million Eur.

EnglandEuropSpainEuropHollandEuropItalyEuropBrasilAmericaArgentinaAmericaChileAmericaMexicoAmerica

Author: M. Sc. Fabio Linares Pazos.Results of the application of VIDATOX 30 CH in patients

VIDATOX 30 CHHow it works?How it is obtained?How it is administered?

CERTIFICATE OF SANITARY REGISTRATION OF THE PRODUCT CECMED-CUBA

Early diagnostic, surgery, chemotherapy, radiotherapy and therapeutic vaccines are the main weapons for cancer treatment in Conventinal Medicine.

The goals of conventional treatments are: -Improvement of the quality of life -To Increase the survival of the patients. -To avoid the recurrence of malignant tumours (metastasis).

Introduction

Oncologic family and treatmets prescribed

Group 2Group 1

Affected organs and neoplasic family

Lungs (Respiratory difficulty, thoracic pain, cough, aggravation of symptoms by effort, anorexia, weight loss)

Prostate gland (Difficulty when urinating, pain, hematuria, difficulty to defecate, anorexia, weight loss)

Colon (Pain, constipation, difficulty to defecate, diarrheas, bleeding, anorexia)

Breasts (Pain, the general health taken, cough, respiratory difficulty)

Uterus (Pain, vaginal secretion, inflammation, bleeding)

Lymphoid tissue ( Hematological upsets, anemia, respiratory difficulty, difficulty when swallowing solids)

Pancreas (Inflammation, anemia, jaundice, increase of glucemia)

Brain (Weakness in extremities, vision's decrease, difficulty when talking, difficulty when swallowing solids)Most frecuent symptoms depending upon the affected organ.

PATIENTS REPORTING IMPROVEMENT IN THE EVOLUTIVE STUDIES

90 patients(64.6%)GROUP 1 19 patients (54,5%) GROUP 2Improvement in 3-9 months treatmet

SEXMONTHSAgefmTotal36912> 1 year80581327112Total92821743054251213

ANALGESIC EFFECT AFTER 30 DAYS OF TREATMENTIN 65.98 % OF THE PATIENTS WAS REPORTED INCREASED PAIN RELIEF

Pain statusBefore treatment%1 month After treatment%01727%11930%3962%23962%58%358%23%6363

Nota: Pain status established according to metodology published by the Hematology and orthopedic services from " Hermanos Ameijeiras Cuban Hospital

Relieve of the pain.Reduction of the inflammatory processes Improvement of the Quality of lifeIncreasing in survivalAbsence of side effectsCONCLUSSIONS

THERE HAS BEEN REPORTED EXPONENTIAL INCREASE IN THE INTAKE OF THE PRODUCT DUE TO PATIENTS OWN DESIRE. TODAY THE PRODUCT IS BEING ADMINISTERED TO MORE THAN 65000 PATIENTS FROM MANY COUNTRIES, AMONG THEM: ITALY, USA, MEXICO, CHILE, COLOMBIA, ARGENTINA, GREECE, SPAIN, PORTUGAL AND CHINA.

VIDATOX 30 CH

WinuE

*